Alzheimer's Disease
Alzheimer's disease is a progressive neurological disorder that leads to memory loss, confusion, and changes in behavior, significantly impacting daily life.
We are investigating whether dimethyl fumarate can improve memory and daily activities in patients with mild cognitive impairment and Alzheimer's disease. This study will also assess its effects on brain health and quality of life.
Health conditions and diseases that the clinical trial is designed to study and treat.
Alzheimer's disease is a progressive neurological disorder that leads to memory loss, confusion, and changes in behavior, significantly impacting daily life.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.